Manni A, Wright C, Feil P, Baranao L, Demers L, Garcia M, Rochefort H
Cancer Res. 1986 Apr;46(4 Pt 1):1594-8.
We have recently shown that the integrity of the polyamine pathway is essential but not sufficient for expression of the mitogenic effect of estradiol (E2) in the N-nitrosomethylurea-induced rat mammary tumor grown in vitro in the soft agar clonogenic assay. To elucidate the mechanism of E2 action in this system, we tested whether E2 may stimulate tumor growth through induction of secretory growth factor(s), as already proposed for human breast cancer cell lines in culture. Furthermore, we investigated the potential interaction between such "autocrine" control of tumor growth by E2 and the polyamine pathway. Conditioned medium obtained from E2-treated tumors (E2-CM) but not from control tumors (C-CM) consistently stimulated colony formation when added to N-nitrosomethylurea-mammary tumors plated in soft agar under serum-free media conditions. Such growth-promoting effects of the E2-CM was found to increase with increasing protein concentrations of the medium and was abolished by pretreatment of the medium with concanavalin A, heat, and trypsin. The addition of the polyamine biosynthetic inhibitor alpha-difluoromethylornithine (1 mM) totally abolished the colony-stimulating effect of the E2-CM. Exogenous administration of spermidine (0.1 mM) reversed the inhibitory effect of alpha-difluoromethylornithine on colony formation and restored the action of the E2-CM. Although the addition of polyamines alone did not affect the number of colonies formed, the administration of spermidine was found to significantly enhance in a dose-dependent fashion the colony-stimulating effect of suboptimal concentrations of E2-CM. Attempts to identify the E2-inducible growth factor in the E2-CM and in N-nitrosomethylurea-mammary tumor specimens using monoclonal antibodies raised against the Mr 52,000 E2-inducible protein gave negative results. We conclude that autocrine stimulation of tumor growth by E2 is not limited to human breast cancer cell lines but also occurs in individual experimental mammary tumors grown in soft agar. Our results show that the polyamines must be present for the expression of this "autocrine" control of tumor growth by E2. Finally, the identity of the E2-induced growth factor operating in our system remains to be determined.
我们最近发现,在软琼脂克隆形成试验中体外培养的N-亚硝基甲基脲诱导的大鼠乳腺肿瘤中,多胺途径的完整性对于雌二醇(E2)促有丝分裂作用的表达至关重要,但并不充分。为了阐明E2在此系统中的作用机制,我们测试了E2是否可能通过诱导分泌性生长因子来刺激肿瘤生长,正如之前针对培养中的人乳腺癌细胞系所提出的那样。此外,我们研究了E2对肿瘤生长的这种“自分泌”控制与多胺途径之间的潜在相互作用。当在无血清培养基条件下添加到接种于软琼脂中的N-亚硝基甲基脲-乳腺肿瘤时,来自E2处理肿瘤的条件培养基(E2-CM)而非对照肿瘤的条件培养基(C-CM)始终能刺激集落形成。发现E2-CM的这种促生长作用随着培养基蛋白浓度的增加而增强,并通过用伴刀豆球蛋白A、加热和胰蛋白酶预处理培养基而被消除。添加多胺生物合成抑制剂α-二氟甲基鸟氨酸(1 mM)完全消除了E2-CM的集落刺激作用。外源性给予亚精胺(0.1 mM)可逆转α-二氟甲基鸟氨酸对集落形成的抑制作用,并恢复E2-CM的作用。虽然单独添加多胺并不影响形成的集落数量,但发现给予亚精胺以剂量依赖性方式显著增强了次优浓度E2-CM的集落刺激作用。使用针对52,000 Mr E2诱导蛋白产生的单克隆抗体,试图在E2-CM和N-亚硝基甲基脲-乳腺肿瘤标本中鉴定E2诱导的生长因子,但结果为阴性。我们得出结论,E2对肿瘤生长的自分泌刺激不仅限于人乳腺癌细胞系,也发生在软琼脂中生长的单个实验性乳腺肿瘤中。我们的结果表明,多胺必须存在才能表达E2对肿瘤生长的这种“自分泌”控制。最后,在我们的系统中起作用的E2诱导生长因子的身份仍有待确定。